Zhou, Linghui1,2,3,4; Fu, Weijun5; Wu, Shenghao1,6; Xu, Kailin7,8; Qiu, Lugui9; Xu, Yang10; Yan, Xiaojing11; Zhang, Qing12; Zhang, Mingming1,2,3,4; Wang, Linqin1,2,3,4; Hong, Ruimin1,2,3,4; Chang, Alex H.13,14; Yu, Jian1,2,3,4; Fu, Shan1,2,3,4; Kong, Delin1,2,3,4; Li, Lu5; Wang, Ying7,8; Li, Zhenyu7,8; Jiang, Huawei10; Huang, Jing12; Liu, Zhi12; Su, Na11; Wei, Guoqing1,2,3,4; Hu, Yongxian1,2,3,4; Huang, He1,2,3,4

1.Bone Marrow Transplantation Center,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,China;
2.Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,China;
3.Institute of Hematology,Zhejiang University,Hangzhou,China;
4.Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy,Hangzhou,China;
5.Department of Hematology,Shanghai Fourth People's Hospital,School of Medicine,Tongji University,Shanghai,China;
6.Department of Hematology,The Dingli Clinical College of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University,Wenzhou Central Hospital),Zhejiang,China;
7.Blood Diseases Institute,Xuzhou Medical University,Xuzhou,China;
8.Department of Hematology,The Affiliated Hospital of Xuzhou Medical University,Xuzhou,China;
9.National Clinical Research Center for Blood Diseases,State Key Laboratory of Experimental Hematology,Blood Diseases & Institute of Hematology,Chinese Academy of Medical Sciences and Peking Union Medical College,Tianjin,China;
10.Department of Hematology,The Second Affiliated Hospital,College of Medicine,Zhejiang University,Hangzhou,China;
11.Department of Hematology,The First Affiliated Hospital of China Medical University,Shenyang,China;
12.Guangdong Second Provincial General Hospital,Guangzhou,China;
13.Shanghai YaKe Biotechnology Ltd,Shanghai,China;
14.Clinical Translational Research Center,Shanghai Pulmonary Hospital,Tongji University School of Medicine,Shanghai,China